Malgorzata McMasters

MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia

Athalia R. Pyzer, Dina Stroopinsky, Hasan Rajabi et al. · Blood · 2017 · 192 citations · Full text

Medicine, Cancer Biology, Oncology +16

Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms

David P. Steensma, Martin Wermke, Virginia M. Klimek et al. · Leukemia · 2021 · 178 citations · Full text

Medicine, Hematology, Pharmacology +14

Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions

Jacalyn Rosenblatt, Richard M. Stone, Lynne Uhl et al. · Science Translational Medicine · 2016 · 164 citations · Full text

Medicine, Immunology, Oncology +17

Results of a Clinical Trial of H3B-8800, a Splicing Modulator, in Patients with Myelodysplastic Syndromes (MDS), Acute Myeloid Leukemia (AML) or Chronic Myelomonocytic Leukemia (CMML)

David P. Steensma, Martin Wermke, Virginia M. Klimek et al. · Blood · 2019 · 89 citations

Medicine, Genetics, Hematology +14

MUC1 inhibition leads to decrease in PD-L1 levels via upregulation of miRNAs

Athalia R. Pyzer, Dina Stroopinsky, Jacalyn Rosenblatt et al. · Leukemia · 2017 · 73 citations · Full text

Life Sciences, Molecular Biology, Oncology +9